About H. Fibiger
Form D filings for GABA Therapeutics in 2023 list H. Fibiger as director.
H. Fibiger first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name H. Fibiger in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people H. Fibiger works with at each company, as listed on that company's latest Form D.
GABA Therapeutics, Inc. · Form D, Oct 10, 2023
RB
Ryan Barrett
Director
SR
Srinivas Rao
Director
MS
Mario Saltarelli
Chief Executive Officer and director
RF
Richard Farrell
Executive officer and director